Announcements Trials

Browse Landscape

Phase

Status

Terminated 4 Withdrawn 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Breast Neoplasms 17 Lung Neoplasms 15 Colonic Neoplasms 11 Head and Neck Neoplasms 9 Rectal Neoplasms 7 Glioblastoma 5 Prostatic Neoplasms 4 Precancerous Conditions 4 Mouth Neoplasms 4 Esophageal Neoplasms 4 Central Nervous System Neoplasms 4 Adenomatous Polyposis Coli 4 Uterine Cervical Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 3 Sarcoma 3 Neuroblastoma 3 Neoplasms 3 Liver Neoplasms 3 Gliosarcoma 3 Glioma 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Smoking 2 Salivary Gland Neoplasms 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2 Multiple Myeloma 2

Interventions

Ipilimumab 114 pembrolizumab 95 Nivolumab 91 aldesleukin 86 Interleukin-2 57 Cyclophosphamide 54 Dacarbazine 52 Vemurafenib 39 trametinib 37 Temozolomide 37 incomplete Freund's adjuvant 35 fludarabine phosphate 35 sargramostim 32 dabrafenib 32 fludarabine 26 Bevacizumab 26 Paclitaxel 22 MART-1 Antigen 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 montanide ISA 51 20 Interferon-alpha 20 Cisplatin 20 Carboplatin 19 Sorafenib 18 Introns 17 Biopsy 17 cobimetinib 16 Radiosurgery 16 atezolizumab 15 Radiotherapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × Celecoxib × Clear all

NCT00197912 2010-04-26

Dendritic Cell Based Therapy of Malignant Melanoma

Herlev Hospital

Phase 1/2 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡